Latest News

8

Oct 19

Zellkraftwerk GmbH wins multiple awards for innovative ChipCytometry platform

ST. LOUIS, Sept. 19, 2019 -- Zellkraftwerk GmbH, a Canopy Biosciences™ company, has won two innovation awards for its groundbreaking...
Read More

29

Apr 19

Canopy Biosciences Acquires Zellkraftwerk GmbH

Simultaneously Closes Strategic Growth Investment from Ampersand Capital to Create a Leading Provider of Genomic and Cell and Tissue Analysis...
Read More

29

Mar 19

Canopy Biosciences Launches New Technology Vastly Improving Sensitivity of Next Generation Sequencing

ST. LOUIS, March 29, 2019 -- Canopy Biosciences™ LLC, a leading provider of gene editing and gene expression products and...
Read More

5

Mar 19

Canopy Biosciences Announces Exclusive License for Error Corrected Sequencing Technology

ST. LOUIS, March 5, 2019 /PRNewswire/ -- Canopy Biosciences™ LLC, a leading provider of gene editing and gene expression products...
Read More
1 4 5 6 7 8 10
0

Start typing and press Enter to search